Wibke Lembke PhD

Wibke Lembke, PhD, is Associate Director Development at Covagen AG, one of the biopharmaceutical companies of Johnson & Johnson. She leads a group whose focus is on bioanalysis of large molecules including PK analysis and immunogenicity testing in non-clinical and clinical settings and outsourcing to CROs. She is Janssen Biologics representative at the European Bioanalysis Forum.

Prior to that, she worked in the drug discovery research in the field of immunology and oncology. In her different roles at Covagen, she gained in-depth knowledge in the drug development process of novel bispecific therapeutics from discovery to early clinical development. She graduated in biochemistry and obtained her PhD from the Technical University of Munich, Germany.